Ozempic: knowledge and creativity regarding wellness and controlling type 2 diabetes

By Dr Mary Williams

Ozempic, a revolutionary medication in the realm of diabetes management, stands as a testament to advancements in pharmacotherapy. Developed by Novo Nordisk, this glucagon-like peptide-1 receptor agonist (GLP-1 RA) has garnered attention for its efficacy in addressing the intricate challenges associated with type 2 diabetes mellitus. Beyond its primary role in glycemic control, Ozempic unfurls additional benefits that resonate with individuals navigating the complex landscape of diabetes. Weight management emerges as a noteworthy ally, as Ozempic has demonstrated a propensity for weight loss, a welcome outcome for those contending with the intricate interplay between diabetes and obesity.

• Format: Paperback
• Language: English
• ISBN: B0CSBFSDJH
• ISBN13: 9798875878701
• Release Date: January 2024
• Publisher: Independently Published
• Length: 102 Pages
• Weight: 0.32 lbs.
• Dimensions: 0.2" x 6.0" x 9.0"